Filters
Cancer immunotherapy rejuvenation of anti-cancer response by immune checkpoint blockade using novel multifunctional nanoparticle to block CTLA-4 and eliminate ICER (TH73020001)
targeting ICER in CTLA-4 positive T cells using mesoporous silica nanoparticles (MSNs specific paratopes trapping CTLA-4. Importantly, these peptides are meant not only to guide ICER RNAi delivery into CTLA
Polymer science
- 2021 - 2023 •
- 12 606 tis. Kč •
- 8 826 tis. Kč •
- TA ČR
Řešení projektu: 1. 1. 2021 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (70%)
Poskytovatel: Technologická agentura ČR
Studies of genetic associations of female reproductive disorders of autoimmune origin HLA class II and CTLA-4 genes (NH6451)
Study on associations of polymorphisms of HLA class II and CTLA-4 gene with female infertility positive for autoantibodies to zona pellucida and/or antiphospholipid autoantibodies.......
FK - Gynekologie a porodnictví
- 2001 - 2003 •
- 1 459 tis. Kč •
- 1 444 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2001 - 1. 1. 2003
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Ministerstvo zdravotnictví
CTLA-4 Ig prophylactic monotherapy and combination with anti-CD4 and anti-TCR in rat aortic allograft model (IZ3060)
9F - 9
- 1995 - 1996 •
- 227 tis. Kč •
- 227 tis. Kč •
- MZ
Řešení projektu: 1. 1. 1995 - 1. 1. 1996
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Non-HLA genetic risk of insulin dependent diabetes mellitus in Czech children a study of IDDM2 and IDDM1 2 genes (NE6503)
Study of non-HLA genetic risk of IDDM in the Czechpopulation. IDDM2 (insulin gene) and IDDM12 (CTLA-4 gene). Assessment of suitability for IDDM prediction. Comparison to other Caucasian populations. Correlation to IDDM incidence.......
FG - Pediatrie
- 2001 - 2003 •
- 1 267 tis. Kč •
- 1 264 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2001 - 1. 1. 2003
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Genetic factors influencing the development of celiac disease in Type 1 diabetic children. (NB7413)
Proposed study will investigate the contribution of susceptible genotypes (HLA-DQ, CTLA4 polymorphism, cytokine genes polymorphism) for the high frequency of celiac disease in children with Type 1 diabetes.......
FB - Endokrinologie, diabetologie, metabolismus, výživa
- 2003 - 2005 •
- 1 815 tis. Kč •
- 1 808 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2003 - 1. 1. 2005
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Prognostic impact of biomarkers and variants in susceptibility genes in systemic lupus erythematosus (NW24J-10-00024)
the entire coding regions of the CTLA-4 and DNASE1 genes, as well as selected loci dysregulation. Next, we will focus on the soluble isoform of the CTLA-4 protein in the blood......
Rheumatology
- 2024 - 2027 •
- 6 831 tis. Kč •
- 6 831 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2024 - 31. 12. 2027
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Role of inhibitory immune checkpoints in Lyme disease (NU23-05-00302)
Immune checkpoints are receptors preventing excessive activation of the immune system and thus keeping the delicate balance between tolerance and immunopathology. Programmed cell death protein 1 (PD-1) and its ligand PD-L1, also CTLA-4
Microbiology
- 2023 - 2026 •
- 6 684 tis. Kč •
- 6 684 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2023 - 31. 12. 2026
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Polymer prodrugs acting as endogenous vaccines for synergic tumor therapy using immunomodulation and immune checkpoint blockade (GA17-08084S)
The principal objective of the project is to study combined tumor treatment, benefiting from chemotherapy based on novel polymer prodrugs acting as endogenous vaccines, inhibition of suppressive activity of myeloid-derived suppressor cells (MDSC) in ...
FD - Onkologie a hematologie
- 2017 - 2021 •
- 8 334 tis. Kč •
- 8 010 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2017 - 31. 12. 2021
Uznané náklady
Podpora ze státního rozpočtu (96%)
Poskytovatel: Grantová agentura České republiky
Complexes of IL-2 and anti-IL-2 mAb with selective stimulatory activity for CD25+ T cells in cancer immunotherapy changing the paradigm (GA22-20548S)
. Most promising antitumor effect of IL-2/JES6 was observed when injected after CTLA-4 plus PD-1 blockage using even highly suboptimal dosage of respective blocking......
Oncology
- 2022 - 2024 •
- 8 330 tis. Kč •
- 8 330 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2022 - 31. 12. 2024
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Grantová agentura České republiky
Electrochemically active calix[4]arenes and their use for preparation of new receptors and (bio)sensors (GA13-21704S)
The project is focused on synthesis, fundamental electrochemical investigations and possible applications of electrochemically active calix[4]arenes as specific receptors and (bio)sensors in electroanalysis. The selected types of molecules i...
CG - Elektrochemie
- 2013 - 2016 •
- 8 517 tis. Kč •
- 8 517 tis. Kč •
- GA ČR
Řešení projektu: 1. 2. 2013 - 31. 12. 2016
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Grantová agentura České republiky
- 1 - 10 out of 2 187